by pragya1 · September 25 air jordan clearance wholesale , 2018


Transparency Market Research (TMR??has published a new report titled,?????Immunoassay Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast buy air jordan clearance shoes , 2018???2026???.??According to the report, the??global immunoassay market??was valued at US$ 16.54 Bn in 2017 and is projected to expand at a CAGR of 6.2% from 2018 to 2026. The report suggests that high prevalence of chronic and infectious diseases, rise in demand for development of new immunoassays and systems, and increase in trend for international accreditations and result comparability across the world are anticipated to drive the global immunoassay market in the next few years. North America and Europe are projected to dominate the global immunoassay market during the forecast period, primarily due to rapidly aging population, well-established health care infrastructure, presence of a large number of in vitro diagnostic players cheap air jordan shoes clearance , and rise in demand for preventive health care in these regions. The immunoassay market in Asia Pacific is projected to expand at a significant CAGR from 2018 to 2026. It can be attributed to rapidly improving health care infrastructure, increase in foreign direct investment in the health care and biotechnology industries in emerging countries, such as, China, India, South Korea, and Malaysia retro air jordans on clearance , and rise in per capita health care expenditure in the region.


Detail Report:


Development of new immunoassays and systems for various medical specialties to fuel global market


Rise in awareness of biomarkers for various chronic diseases has driven industry experts and researchers to develop new assays to expand the applications of immunoassay analyzers. Development in genomics and proteomics has expanded the database of biomarkers used by industry players to develop new assays that cascade the onset of a disease or disorder. For example, there has been a development of vitamin D deficiency testing chemiluminescence assay, which was earlier diagnosed through manual ELISA methods. Key players are investing in the development of novel immunoassays in the infectious disease domain with the help of the growing database on genetics and biomarkers of various infectious pathogens. Though new molecular diagnostics tests are being developed for infectious diseases, they lack high throughput and short test time features, which make immunoassay analyzers, such as, ELISA cheap air jordan clearance , CLIA, and IFA the preferred choices. In March 2018, Roche launched the first fully-automated Zika IgG immunoassay, called Elecsys Zika IgG, targeted for the CE-marked countries. Rise in awareness regarding early detection and diagnosis of autoimmune disorders has resulted in the development of new immunoassay systems and assays by the leading players in IVD industry. For example, in December 2017, Innova diagnostics launched the next-generation EIA & IFA Processor QUANTA-Lyser 3000 for the diagnosis of autoimmune disorder in clinical laboratory. Thus air jordan retro clearance , the development of new immunoassays and systems to address the current unmet needs and upcoming challenges in health care diagnostics is projected to be a leading driver of the global immunoassay market during the forecast period.


Consumables to be highly attractive segment owing to high volume consumption and low cost


The report offers a detailed segmentation of the global immunoassay market based on product type. The consumables segment is poised to account for the leading share of the global market during the forecast period. The segment comprises immunoassays, test kits, reagents, calibrators, controls, diluents, buffers air jordan clearance outlet , and wash solutions used while performing immunoassay.?? These products have a short lifespan and are primarily meant for single use. Wide availability of consumables and low investment in product development are the major reasons behind the fragmented scenario of the segment. Dominant market share of the consumables segment can be directly attributed to the high number of immunoassay tests performed for the diagnosis of various diseases. As most of the consumables are disposable in nature, they are frequently and repeatedly used for conducting new immunoassay tests. Moreover, technological advancement in immunoassay techniques, such as chemiluminescence immunoassay (CLIA), and increasing adoption of the CLIA technique in developed countries are projected to augment the segment during the forecast period.